Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Drug Safety
|
November 24, 2004
Fab antibody fragments: some applications in clinical toxicology
Robert J Flanagan, Alison L Jones
Forensic Science International
|
May 8, 2019
Detection of fentanyl and fentanyl analogues in biological samples using liquid chromatography-high resolution mass spectrometry
Edmund Rab, Robert J Flanagan, Simon Hudson
Toxicological Reviews
|
July 27, 2005
Analytical toxicology: guidelines for sample collection postmortem
Robert J Flanagan, Geraldine Connally, Julie M Evans
Journal of Clinical Psychopharmacology
|
September 8, 2023
Assessing Adherence to Clozapine: Practical Considerations
Robert J Flanagan, Samora Hunter, Stephen J Obee
Biomedical Chromatography : BMC
|
July 28, 2009
HPLC of basic drugs using non-aqueous ionic eluents: evaluation of a 3 mum strong cation-exchange material
Phillip E Morgan, Victoria Manwaring, Robert J Flanagan
Journal of Analytical Toxicology
|
June 14, 2014
Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis)
Sarah L Belsey, Lewis Couchman, Robert J Flanagan
Human Psychopharmacology
|
March 19, 2011
Haematological toxicity of clozapine and some other drugs used in psychiatry
Patty M M Nooijen, Felix Carvalho, Robert J Flanagan
Clinical Toxicology (Philadelphia, Pa.)
|
April 13, 2013
Unintentional domestic non-fire related carbon monoxide poisoning: data from media reports, UK/Republic of Ireland 1986-2011
Danielle S Fisher, Sally Bowskill, Lynn Saliba, et al.
Biomedical Chromatography : BMC
|
January 14, 2012
Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS
Danielle S Fisher, Simon A Handley, David Taylor, et al.
General Hospital Psychiatry
|
July 24, 2017
Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine
Susanna Every-Palmer, Pete M Ellis, Robert J Flanagan, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Drug Safety
|
November 24, 2004
Fab antibody fragments: some applications in clinical toxicology
Robert J Flanagan, Alison L Jones
Forensic Science International
|
May 8, 2019
Detection of fentanyl and fentanyl analogues in biological samples using liquid chromatography-high resolution mass spectrometry
Edmund Rab, Robert J Flanagan, Simon Hudson
Toxicological Reviews
|
July 27, 2005
Analytical toxicology: guidelines for sample collection postmortem
Robert J Flanagan, Geraldine Connally, Julie M Evans
Journal of Clinical Psychopharmacology
|
September 8, 2023
Assessing Adherence to Clozapine: Practical Considerations
Robert J Flanagan, Samora Hunter, Stephen J Obee
Biomedical Chromatography : BMC
|
July 28, 2009
HPLC of basic drugs using non-aqueous ionic eluents: evaluation of a 3 mum strong cation-exchange material
Phillip E Morgan, Victoria Manwaring, Robert J Flanagan
Journal of Analytical Toxicology
|
June 14, 2014
Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis)
Sarah L Belsey, Lewis Couchman, Robert J Flanagan
Human Psychopharmacology
|
March 19, 2011
Haematological toxicity of clozapine and some other drugs used in psychiatry
Patty M M Nooijen, Felix Carvalho, Robert J Flanagan
Clinical Toxicology (Philadelphia, Pa.)
|
April 13, 2013
Unintentional domestic non-fire related carbon monoxide poisoning: data from media reports, UK/Republic of Ireland 1986-2011
Danielle S Fisher, Sally Bowskill, Lynn Saliba, et al.
Biomedical Chromatography : BMC
|
January 14, 2012
Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS
Danielle S Fisher, Simon A Handley, David Taylor, et al.
General Hospital Psychiatry
|
July 24, 2017
Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine
Susanna Every-Palmer, Pete M Ellis, Robert J Flanagan, et al.
Page
of 6